发明名称 |
METHODS FOR CLASSIFYING A CANCER AS SUSCEPTIBLE TO TMEPAI-DIRECTED THERAPIES AND TREATING SUCH CANCERS |
摘要 |
The invention provides methods for classifying a cancer as susceptible to transmembrane prostate androgen induced (TMEPAI)-directed therapies, and methods for treating such cancers. The field of the invention pertains generally to medicine, pathology and oncology. More particularly, it addresses the treatment of breast cancer, such as triple-negative breast cancer, using a transmembrane prostate androgen induced (TMEPAI)-directed therapy. |
申请公布号 |
US2016000735(A1) |
申请公布日期 |
2016.01.07 |
申请号 |
US201414769504 |
申请日期 |
2014.02.26 |
申请人 |
THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM |
发明人 |
SAIKUMAR Pothana;SINGHA Prajjal Kanti |
分类号 |
A61K31/19;G01N33/574;A61K45/06;C12N15/113 |
主分类号 |
A61K31/19 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of inhibiting a cancer cell that overexpresses transmembrane prostate androgen induced (TMEPAI) compared to normal control cell comprising contacting the cancer cell with an agent that inhibits TMEPAI expression or activity. |
地址 |
Austin, TX US |